Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS Should Fully Automate ASP Data Submissions, OIG Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Manufacturers’ submissions of average sales price data from drugs are entered manually by CMS staff; the HHS Inspector General recommends a fully automated process like the one used for average manufacturer price submissions.

You may also be interested in...

CMS Should Verify Part B Drug Pricing From Manufacturers, GAO Says

CMS 'concurs' with GAO’s recommendation on ASP reports but it’s unclear how much more aggressively it will pursue underlying documentation.

OIG Report Highlights Difficulty In Measuring “Widely Available Market Price” For Drugs

Limitations and irregularities in sales data prevent an accurate comparison of average sales price and widely available market price for Medicare Part B drugs, a differential that can be the basis for modifying reimbursement.

GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds

New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts